| Accession |
447 |
| Title |
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab |
| Summary |
This nonrandomized phase I/II trial assessed the efficacy/tolerability of imatinib plus panitumumab in patients affected by metastatic colorectal cancer (mCRC) after stratification to treatment by selection of activated imatinib drug targets using reverse-phase protein array (RPPA). |
| Journal |
J Proteome Res. |
| Publish date |
May, 2014 |
| Corresponding Author |
E. Petricoin |
| E-mail |
epetrico@gmu.edu |
| Array Type |
Reverse phase protein array |
| Species |
Homo sapiens |
| Raw data link |
No relevant experiment link!
|
| Link to PubMed |
PubMed ID:24787230
|
